Clinical Trial Update: Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating 10 mg adefovir dipivoxil in Chinese patients with HBeAg-negative chronic hepatitis B has been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2009-10-02